BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15925982)

  • 21. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
    Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
    Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
    Richards GM; Tomé WA; Robins HI; Stewart JA; Welsh JS; Mahler PA; Howard SP
    Breast Cancer Res Treat; 2009 Mar; 114(2):307-13. PubMed ID: 18389365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No correlation between radiosensitivity or double-strand break repair capacity of normal fibroblasts and acute normal tissue reaction after radiotherapy of breast cancer patients.
    El-Awady RA; Mahmoud M; Saleh EM; El-Baky HA; Lotayef M; Dahm-Daphi J; Dikomey E
    Int J Radiat Biol; 2005 Jul; 81(7):501-8. PubMed ID: 16263653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
    Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.
    Koukourakis MI; Tsoutsou PG; Abatzoglou IM; Sismanidou K; Giatromanolaki A; Sivridis E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1173-80. PubMed ID: 19058920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements.
    Huang CJ; Hou MF; Luo KH; Wei SY; Huang MY; Su SJ; Kuo HY; Yuan SS; Chen GS; Hu SC; Chuang HY
    Breast; 2015 Jun; 24(3):230-6. PubMed ID: 25777626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin-sparing radiation using intensity-modulated radiotherapy after conservative surgery in early-stage breast cancer: a planning study.
    Saibishkumar EP; MacKenzie MA; Severin D; Mihai A; Hanson J; Daly H; Fallone G; Parliament MB; Abdulkarim BS
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):485-91. PubMed ID: 17881140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of axillary deodorant and effect on acute skin toxicity during radiotherapy for breast cancer: a prospective randomized noninferiority trial.
    Théberge V; Harel F; Dagnault A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1048-52. PubMed ID: 19327906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-induced stress response in peripheral blood of breast cancer patients differs between patients with severe acute skin reactions and patients with no side effects to radiotherapy.
    Skiöld S; Naslund I; Brehwens K; Andersson A; Wersall P; Lidbrink E; Harms-Ringdahl M; Wojcik A; Haghdoost S
    Mutat Res; 2013 Aug; 756(1-2):152-7. PubMed ID: 23652022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.
    Taylor ME; Haffty BG; Rabinovitch R; Arthur DW; Halberg FE; Strom EA; White JR; Cobleigh MA; Edge SB
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):997-1002. PubMed ID: 19251087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioprotective effect of moderate wine consumption in patients with breast carcinoma.
    Morganti AG; Digesù C; Panunzi S; De Gaetano A; Macchia G; Deodato F; Cece MG; Cirocco M; Di Castelnuovo A; Iacoviello L; Valentini V; Cellini N; de Gaetano G
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1501-5. PubMed ID: 19395196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.
    Pignol JP; Rakovitch E; Keller BM; Sankreacha R; Chartier C
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1482-8. PubMed ID: 18930602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe acute radiation-related skin toxicity in a breast cancer patient with Behçet's disease.
    Chargari C; Kirova YM; Fourquet A; Campana F
    Radiother Oncol; 2009 Apr; 91(1):139. PubMed ID: 19014876
    [No Abstract]   [Full Text] [Related]  

  • 40. Early intestinal changes following abdominal radiotherapy comparison of endpoints.
    Dörr W; Köst S; Keinert K; Glaser FH; Endert G; Herrmann T
    Strahlenther Onkol; 2006 Jan; 182(1):1-8. PubMed ID: 16404514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.